GMP und ATMPs
Live Webcast am 12. Februar 2019 um 10:30 Uhr
- Aktuelle Anforderungen
- Erste Erfahrungen
Dr. Christian van den Boes
Gründer von Mares Ltd., Qualified Person (QP) für ATMPs
Christian van den Bos, Ph.D., founded Mares Ltd in 2006 to drive innovation in biologics with a focus on therapeutic cells and tissue engineered products; Mares provides both consulting services as well as develops its own intellectual property.
He has put a tissue engineered product on the German market, designed processes and designed and executed facilities as well as quality systems in Europe, USA and Asia. He headed an innovation program at Lonza, a pharmaceutical contract manufacturer, and served in responsible positions at various US, Swiss and German start-up biotech companies. Most recently, he has supported the MSD’s effort to set up an Ebola vaccine manufacturing project.
Dr. van den Bos has been recognized as qualified Person (QP) acc. to EU drug law and has published widely on cellular drugs, their manufacture and regulatory aspects. As of 2013, he serves on the board of Directors of the German Society for Regenerative Medicine.
Dr. van den Bos received post-doctoral training at Cold Spring Harbor Laboratories, USA, earned a Ph.D. at the University of Münster, Germany, and an M.Sc. at the University of Oxford, UK.